Journals / İstanbul Kuzey Klinikleri / 2015 / Cilt: 2 - Sayı: 3

TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals

Pages
203–209
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although seroprevalence of rubella is also high, it may be suggested for preconception vaccination especially in women above 20 years of age born prior to National Vaccination Programme.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Toxoplasma gondii, Rubella, Cytomegalovirus and Herpes simplex viruses are microorganisms that cause congenital infections and they are called briefly as TORCH.
📊
Key Findings & Data:METHODS: A total of 1101 patients attending outpatient clinic of Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals between September 2013 to January 2015 and their laboratory data were evaluated retrospectively.
💡
Conclusion & Impact:Although seroprevalence of rubella is also high, it may be suggested for preconception vaccination especially in women above 20 years of age born prior to National Vaccination Programme.
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Toxoplasma gondii, Rubella, Cytomegalovirus and Herpes simplex viruses are microorganisms that cause congenital infections and they are called briefly as TORCH. There is an ongoing argument for the screening of reproductive age women due to the high cost of tests. For a test to be used in screening, prevalence of disease in this population should be known. The aim of this study was to investigate TORCH seroprevalence among women attending a teaching hospital in Istanbul. METHODS: A total of 1101 patients attending outpatient clinic of Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals between September 2013 to January 2015 and their laboratory data were evaluated retrospectively. We investigated Ig G and M seropositivity rates against TORCH. RESULTS: The age of the patients ranged between 17 47 years with a mean age of 30.3±5.8 years. Pregnant population had 99.5% anti-CMV Ig G (+), 94.2% anti-Rubella Ig G (+), 31% anti-Toxoplasma Ig G (+). Seroprevalence for Anti IgM was 0.5% for CMV, 0.2% for rubella. CONCLUSION: The screening for Toxoplasma gondii may be suggested since the prevalence is not high in our population. The screening of CMV is not meaningful, due to high seroprevalence. Although seroprevalence of rubella is also high, it may be suggested for preconception vaccination especially in women above 20 years of age born prior to National Vaccination Programme.

🔖

Cite This Article

AKA, N., VURAL, F., ERTURK, A. D. C., ALPAY, M., NUMAN, O. (2022). TORCH seroprevalence among patients attending Obstetric Care Clinic of Haydarpasa Training and Research Hospital affiliated to Association of Istanbul Northern Anatolia Public Hospitals. İstanbul Kuzey Klinikleri, Cilt: 2 - Sayı: 3, 203–209. https://ajindex.com/articles/551697

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kır M, et al. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet 2014;290:1115–20
  2. Yamamoto R, Ishii K, Shimada M, Hayashi S, Hidaka N, Nakayama M, et al. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction. J Obstet Gynaecol Res 2013;39:653–7
  3. Patel KK, Shrivastava G, Bhatambare G, Bajpai T. Antenatal detection of Ig M and Ig G antibodies to Toxoplasma gondii in a hospital from central India. Int J Health Sys and Disaster Man 2014;2:133–5
  4. Feldman DM, Timms D, Borgida AF. Toxoplasmosis, parvovirus, and cytomegalovirus in pregnancy. Clin Lab Med 2010;30:709– 20
  5. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA; South Australian Cerebral Palsy Research Group. Neurotropic viruses and cerebral palsy: population based case-control study. BMJ 2006;332:76–80
  6. Jahromi AS, Kazemi A, Manshoori G, Madani A, Moosavy SH, Seddigh B. Seroprevalence of Rubella virüs in women with spontaneus abortion. Am J Inf Dis 2011;7:16–9
  7. Duran B, Toktamis A, Erden O, Demirel Y, Mamik BA, Cetin M. Doğum öncesi bakımda tartışmalı bir konu: TORCH taraması. C.Ü. Tıp Fakültesi Derg 2002;24:185–90
  8. Abdel-Fattah SA, Bhat A, Illanes S, Bartha JL, Carrington D. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028–31
  9. Chaudhry SA, Gad N, Koren G. Toxoplasmosis and pregnancy. Can Fam Physician 2014;60:334–6
  10. Remington JS, McLeod R, Wilson CB, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA eds. Infectious Diseases of the Fetus and Newborn Infant. Elsevier-Saunders, 7th ed, Philadelphia, PA, 2011. p. 918–1041
  11. Karabulut A, Polat Y, Türk M, Isik Balci Y. Evaluation of rubella, toxoplasma gondii and cytomegalo virus seroprevalemces among pregnant women in Denizli province. Turk J Med Sci 2011;41:159–64
  12. Dogan K, Kafkaslı A, Karaman U, Atambay M, Karaoğlu L, Colak C. The rates of seropositivity and seroconversion of toxoplasma infection in pregnant women. Mikrobiyol Bul 2012;46:290–4
  13. Tekay F, Ozbek E. The seroprevalence of Toxoplasma gondii in women from Sanliurfa, a province with a high raw meatball consumption. Turkiye Parazitol Derg 2007;31:176–9
  14. Ocak S, Zeteroglu S, Ozer C, Dolapci